Oceansbio

Oceansbio

Revolutionizing health care with AI-driven electroceuticals, Oceansbio offers non-invasive solutions for neurological conditions, enhancing life quality globally.

Oceansbio focuses on the development of innovative medical devices based on AI technology. Their flagship product, TaVNS, is designed to alleviate neurological disorders by delivering electrical impulses to the vagus nerve, offering a non-invasive treatment option for conditions like epilepsy, depression, and stress.

Oceansbio envisions a future where individuals worldwide can maintain their health and well-being through advanced medical solutions. Our mission is to create hyper-personalized electroceutical devices that empower people to lead healthier lives.

Noteworthy Achievements:

  • Secured pre-Series A funding from notable investors.
  • Won 1st place at the ‘Youth Startup Accelerator Demo Day’.
  • Signed MOUs with local companies at CES 2024.

 

Picture Gallery

Comments are closed.